These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 1538123)

  • 1. Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus.
    Wisnieski JJ; Jones SM
    J Immunol; 1992 Mar; 148(5):1396-403. PubMed ID: 1538123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG autoantibody to the collagen-like region of Clq in hypocomplementemic urticarial vasculitis syndrome, systemic lupus erythematosus, and 6 other musculoskeletal or rheumatic diseases.
    Wisnieski JJ; Jones SM
    J Rheumatol; 1992 Jun; 19(6):884-8. PubMed ID: 1404125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Western blot analysis of human IgG reactive with the collagenous portion of C1q: evidence of distinct binding specificities.
    Mårtensson U; Sjöholm AG; Sturfelt G; Truedsson L; Laurell AB
    Scand J Immunol; 1992 Jun; 35(6):735-44. PubMed ID: 1604245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies in systemic lupus erythematosus and urticarial vasculitis.
    D'Cruz DP; Wisnieski JJ; Asherson RA; Khamashta MA; Hughes GR
    J Rheumatol; 1995 Sep; 22(9):1669-73. PubMed ID: 8523343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to the collagen-like region of C1q and type II collagen are independent non-cross-reactive populations in systemic lupus erythematosus and rheumatoid arthritis.
    Cook AD; Rowley MJ; Wines BD; Mackay IR
    J Autoimmun; 1994 Jun; 7(3):369-78. PubMed ID: 7522456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum IgG antibodies to C1q in hypocomplementemic urticarial vasculitis syndrome.
    Wisnieski JJ; Naff GB
    Arthritis Rheum; 1989 Sep; 32(9):1119-27. PubMed ID: 2528353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assay, purification and further characterization of 7S C1q-precipitins (C1q-p) in hypocomplementemic vasculitis urticaria syndrome and systemic lupus erythematosus.
    Marder RJ; Potempa LA; Jones JV; Toriumi D; Schmid FR; Gewurz H
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():25-34. PubMed ID: 6375256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypocomplementemic urticarial vasculitis or systemic lupus erythematosus?
    Trendelenburg M; Courvoisier S; Späth PJ; Moll S; Mihatsch M; Itin P; Schifferli JA
    Am J Kidney Dis; 1999 Oct; 34(4):745-51. PubMed ID: 10516358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells.
    Bigler C; Schaller M; Perahud I; Osthoff M; Trendelenburg M
    J Immunol; 2009 Sep; 183(5):3512-21. PubMed ID: 19648280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Anti-C1q Autoantibodies by Western Blot.
    Verlemyr A; Truedsson L; Skattum L
    Methods Mol Biol; 2019; 1901():183-189. PubMed ID: 30539577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of high salt concentration on detection of serum immune complexes and autoantibodies to C1q in patients with systemic lupus erythematosus.
    Kohro-Kawata J; Wener MH; Mannik M
    J Rheumatol; 2002 Jan; 29(1):84-9. PubMed ID: 11824976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial analysis of autoantibody responses to the collagen-like region of Clq, collagen type II, and double stranded DNA in patients with systemic lupus erythematosus.
    Sjoholm AG; Martensson U; Sturfelt G
    J Rheumatol; 1997 May; 24(5):871-8. PubMed ID: 9150075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypocomplementemic urticarial vasculitis: a rare presentation of systemic lupus erythematosus.
    Aydogan K; Karadogan SK; Adim SB; Tunali S
    Int J Dermatol; 2006 Sep; 45(9):1057-61. PubMed ID: 16961508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based enzyme-linked immunosorbent assay.
    Vanhecke D; Roumenina LT; Wan H; Osthoff M; Schaller M; Trendelenburg M
    Arthritis Rheum; 2012 Nov; 64(11):3706-14. PubMed ID: 22740328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic profile of normocomplementemic and hypocomplementemic urticarial vasculitis: a study from South India.
    Dincy CV; George R; Jacob M; Mathai E; Pulimood S; Eapen EP
    J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):789-94. PubMed ID: 18331318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of autoantibodies against the globular domain of human C1q in the sera of systemic lupus erythematosus patients.
    Tsacheva I; Radanova M; Todorova N; Argirova T; Kishore U
    Mol Immunol; 2007 Mar; 44(8):2147-51. PubMed ID: 17049989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies to the collagen-like region of C1q are strongly associated with classical pathway-mediated hypocomplementemia in systemic lupus erythematosus.
    Frémeaux-Bacchi V; Weiss L; Demouchy C; Blouin J; Kazatchkine MD
    Lupus; 1996 Jun; 5(3):216-20. PubMed ID: 8803893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-C1q autoantibodies in lupus nephritis.
    Sinico RA; Rimoldi L; Radice A; Bianchi L; Gallelli B; Moroni G
    Ann N Y Acad Sci; 2009 Sep; 1173():47-51. PubMed ID: 19758131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-C1q autoantibodies.
    Kallenberg CG
    Autoimmun Rev; 2008 Sep; 7(8):612-5. PubMed ID: 18606253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.